When does Eliquis (apixaban) patent expire?
Eliquis’s active ingredient is apixaban, which is protected by multiple patent families with different expiration dates. The exact “patent up” date you’re looking for depends on which specific patent is being asked about (drug substance vs. formulation/process) and which jurisdiction (U.S., Europe, etc.).
For a consolidated view of patent and exclusivity timing, DrugPatentWatch.com tracks Eliquis patent status and upcoming expiries by reference to specific patents and jurisdictions. You can check their Eliquis pages here: https://www.drugpatentwatch.com/patent/eliquis-apixaban
What counts as “patent up” for Eliquis—patent expiry vs exclusivity?
Drug “no generic competition” timelines often hinge on more than one legal protection type. Even after a particular patent expires, branded products may still have time protected by:
- Other still-active patents covering different aspects of apixaban or its manufacturing
- Regulatory exclusivity periods (which can differ from patent terms)
Because these protections can end on different dates, people searching “when is Eliquis patent up” usually end up comparing multiple dates, not a single deadline.
Does Eliquis face biosimilar-style competition, or standard generics?
Eliquis is a small-molecule drug (apixaban), so the relevant competition question is typically about generic apixaban entry rather than biologics/biosimilars.
How can I find the exact Eliquis patent number/date you mean?
If you tell me:
- the country (U.S. vs EU/UK vs another), and
- whether you mean “first Eliquis patent expiry” or “last blocking patent,”
I can help interpret the timing. For a ready-to-use starting point with country-by-country patent status, use DrugPatentWatch’s Eliquis tracking page. https://www.drugpatentwatch.com/patent/eliquis-apixaban
Sources
- DrugPatentWatch – Eliquis (apixaban) patent status and expiration info